ARMP Net Income Growth
Armata Pharmaceuticals, Inc. Common Stock · Net Income Growth
ARMP Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-647.57%period ending
ARMP TTM Net Income YoY % (-64.71% → -647.57%)
Year-over-year change
High-resolution chart · PNG
ARMP net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -647.5707% | |
| -66,241.3146% | |
| -818.7936% | |
| -13.3888% | |
| 61.656% | |
| 99.4647% | |
| 72.6034% | |
| 30.4964% | |
| -81.3689% | |
| -86.6535% | |
| -87.0277% | |
| -82.2726% | |
| -25.4965% | |
| -61.2809% | |
| -59.4342% | |
| -37.578% | |
| -22.3113% | |
| -16.975% | |
| -4.3911% | |
| -17.8176% | |
| -12.9073% | |
| -8.5503% | |
| -14.589% | |
| -5.5104% | |
| -55.2103% | |
| -65.3141% | |
| -59.8431% | |
| -88.237% | |
| -47.5255% | |
| 1.0451% | |
| 5.6707% | |
| 49.2545% | |
| 56.839% | |
| 32.9222% | |
| 31.8505% | |
| -72.7548% | |
| -474.7537% | |
| -274.6157% | |
| -3,550.7752% | |
| -661.0572% | |
| -121.06% | |
| -48.0988% | |
| -102.1393% | |
| -93.2178% | |
| 145.0742% | |
| 130.7523% | |
| 141.2936% | |
| 147.2316% | |
| -376.1888% | |
| -1,595.4525% | |
| 68.8704% | |
| 47.8647% | |
| -21.5678% | |
| -28.4802% | |
| -45.852% | |
| -47.1792% | |
| 53.9391% | |
| 52.5537% | |
| 73.2808% | |
| 74.5225% | |
| -86.7346% | |
| -77.0497% | |
| -114.5407% | |
| -173.8183% | |
| -29.7562% | |
| -34.6567% | |
| 2.5409% | |
| 9.0327% | |
| 25.3963% | |
| 3.8832% | |
| -25.4875% | |
| 12.1753% | |
| -3.6831% | |
| 37.5899% | |
| 43.2383% | |
| 33.1004% | |
| 33.4492% | |
| 12.5281% | |
| 19.6204% | |
| 46.9629% | |
| 46.231% | |
| 42.9839% | |
| 14.8557% | |
| -108.405% | |
| -87.8501% | |
| -78.4831% | |
| -69.4685% | |
| -142.7596% | |
| -251.4545% | |
| -203.4091% | |
| -52.0548% | |
| 25.7143% | |
| 47.2603% | |
| 38.4615% | |
| -9.7744% | |
| 0% | |
| 45.1128% | |
| 45% | |
| 47.8431% | |
| 42.1488% |